- Rubis reported third-quarter revenue of €1.58 billion.
- The company’s business volumes increased by 6% during the period.
- Group EBITDA guidance for 2025 is reaffirmed between €710 million to €760 million.
- This guidance assumes no change in the hyperinflation impact compared to 2024.
- The company attributed its ongoing success to disciplined execution and agile team performance.
- Currently, there are 7 buy recommendations, 1 hold, and no sell recommendations for Rubis.
A look at Rubis SCA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts utilizing the Smartkarma Smart Scores have evaluated Rubis SCA and provided an insightful outlook on the company’s long-term prospects. With a strong score of 5 in the Dividend category, Rubis SCA demonstrates a robust ability to provide consistent and rewarding dividends to its investors. Additionally, the company scored a solid 4 in Growth and Momentum, highlighting its potential for future expansion and positive market performance.
Rubis SCA‘s overall outlook is further supported by its respectable scores of 3 in both Value and Resilience. These scores indicate that the company offers reasonable value to investors and possesses a level of stability to navigate challenging market conditions. With its core operations in distributing liquefied petroleum gas and storing various bulk liquids, including hydrocarbons and chemicals, Rubis SCA shows promising prospects for sustained growth and income generation in the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
